Keyword search (4,163 papers available)

"epidemiology" Keyword-tagged Publications:

Title Authors PubMed ID
1 Updated Status of Physical Activity Research for People With Traumatic Brain Injury Quilico EL; Driver SJ; 41606762
CONCORDIA
2 Impact of COVID-19 on incidence and trends of adverse events among hospitalised patients in Calgary, Canada: a retrospective chart review study Wu G; Eastwood CA; Cheligeer C; Southern DA; Zeng Y; Ghali WA; Bakal JA; Boussat B; Flemons W; Forster A; Xu Y; Quan H; 41592994
CONCORDIA
3 Effect of body image perception and skin-lightening practices on mental health of Filipino emerging adults: a mixed-methods approach protocol Regencia ZJG; Gouin JP; Ladia MAJ; Montoya JC; Baja ES; 37192806
PSYCHOLOGY
4 Geospatial analysis reveals a hotspot of fecal bacteria in Canadian prairie lakes linked to agricultural non-point sources Oliva A; Onana VE; Garner RE; Kraemer SA; Fradette M; Walsh DA; Huot Y; 36653256
BIOLOGY
5 Body-composition phenotypes and their associations with cardiometabolic risks and health behaviours in a representative general US sample Kakinami L; Plummer S; Cohen TR; Santosa S; Murphy J; 36183799
PERFORM
6 Household income and maternal education in early childhood and activity-limiting chronic health conditions in late childhood: findings from birth cohort studies from six countries Spencer NJ; Ludvigsson J; You Y; Francis K; Abu Awad Y; Markham W; Faresjö T; Goldhaber-Fiebert J; Andersson White P; Raat H; Mensah F; Gauvin L; McGrath JJ; 35863874
PERFORM
7 Comparison of different severe obesity definitions in predicting future cardiometabolic risk in a longitudinal cohort of children Kakinami L; Smyrnova A; Paradis G; Tremblay A; Henderson M; 35705336
PERFORM
8 COVID-19-Related Concerns and Symptoms of Anxiety: Does Concern Play a Role in Predicting Severity and Risk? Benzouak T; Gunpat S; Briner EL; Thake J; Kisely S; Rao S; 34987892
PSYCHOLOGY
9 The occurrence of potentially pathogenic fungi and protists in Canadian lakes predicted using geomatics, in situ and satellite-derived variables: Towards a tele-epidemiological approach Oliva A; Garner RE; Walsh D; Huot Y; 34915335
BIOLOGY
10 Discovery of new vascular disrupting agents based on evolutionarily conserved drug action, pesticide resistance mutations, and humanized yeast Garge RK; Cha HJ; Lee C; Gollihar JD; Kachroo AH; Wallingford JB; Marcotte EM; 34849907
BIOLOGY
11 Overestimation of Postpartum Depression Prevalence Based on a 5-item Version of the EPDS: Systematic Review and Individual Participant Data Meta-analysis Thombs BD; Levis B; Lyubenova A; Neupane D; Negeri Z; Wu Y; Sun Y; He C; Krishnan A; Vigod SN; Bhandari PM; Imran M; Rice DB; Azar M; Chiovitti MJ; Saadat N; Riehm KE; Boruff JT; Cuijpers P; Gilbody S; Ioannidis JPA; Kloda LA; Patten SB; Shrier I; Ziegelstein RC; Comeau L; Mitchell ND; Tonelli M; Barnes J; Beck CT; Bindt C; Figueiredo B; Helle N; Howard LM; Kohlhoff J; Kozinszky Z; Leonardou AA; Radoš SN; Quispel C; Rochat TJ; Stein A; Stewart RC; Tadinac M; Tandon SD; Tendais I; Töreki A; Tran TD; Trevillion K; Turner K; Vega-Dienstmaier JM; Benedetti A; 33104415
LIBRARY
12 Weight cycling is associated with adverse cardiometabolic markers in a cross-sectional representative US sample Kakinami L; Knäuper B; Brunet J; 32366587
PERFORM
13 Income inequality and social gradients in children's height: a comparison of cohort studies from five high-income countries. Bird PK, Pickett KE, Graham H, Faresjö T, Jaddoe VWV, Ludvigsson J, Raat H, Seguin L, Wijtzes AI, McGrath JJ 31909223
PSYCHOLOGY

 

Title:Impact of COVID-19 on incidence and trends of adverse events among hospitalised patients in Calgary, Canada: a retrospective chart review study
Authors:Wu GEastwood CACheligeer CSouthern DAZeng YGhali WABakal JABoussat BFlemons WForster AXu YQuan H
Link:https://pubmed.ncbi.nlm.nih.gov/41592994/
DOI:10.1136/bmjqs-2024-018182
Publication:BMJ quality & safety
Keywords:Adverse events, epidemiology and detectionChart review methodologiesPatient Safety
PMID:41592994 Category: Date Added:2026-01-28
Dept Affiliation: CONCORDIA
1 Health Care Management, Cape Breton University, Sydney, Nova Scotia, Canada.
2 Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
3 Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada caeastwo@ucalgary.ca.
4 Centre for Health Informatics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
5 Cancer Care Alberta, Calgary, Alberta, Canada.
6 Concordia University, Montreal, Quebec, Canada.
7 Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
8 Vice President's Office, University of Calgary, Calgary, Alberta, Canada.
9 Health Shared Services, University of Alberta, Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada.
10 Quality of Care Unit, University Hospital Centre Grenoble Alpes, Grenoble, France.
11 Department of Medicine, McGill University, Montreal, Quebec, Canada.
12 Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Description:

Background: While the incidence of hospital adverse events appeared to be declining before 2019, the COVID-19 pandemic may have changed its course. This study aimed to evaluate adverse event incidence rates and trends during the pandemic and analyse differences in patient outcomes.

Methods: This retrospective electronic chart review included a random sample of adult patients admitted to four acute care hospitals in Calgary between 2017 and 2022. 18 adverse events and patient information were extracted. We calculated the observed and risk-standardised incidence rates of adverse events. Interrupted time series analysis was employed to determine the impact of COVID-19 on adverse events trends. Outcome differences were evaluated using mixed-effects logistic regression and negative binomial models.

Results: Among 10 673 patient admissions, 2310 adverse events were identified, resulting in an incidence rate of 21.64 (95% CI 20.77 to 22.54) per 100 patient admissions, or 26.85 (95% CI 25.77 to 27.97) per 1000 patient days. After adjusting for patient characteristics, seasonal variations and overall trends, the adverse event incidence rate increased by 14% (incidence rate ratio (IRR) 1.14, 95% CI 1.01 to 1.29) during the COVID-19 pandemic. In multivariable mixed-effects models, adverse events were associated with significantly longer hospital stays (IRR 3.13, 95% CI 2.97 to 3.30), increased odds of 30-day readmission (OR 1.4, 95% CI 1.17 to 1.68) and in-hospital death (OR 1.72, 95% CI 1.43 to 2.08).

Conclusion: The incidence of adverse events was high but relatively stable in acute healthcare settings before the COVID-19 pandemic and increased during the pandemic. Strengthening healthcare resilience and prioritising patient safety initiatives are crucial as we transition into the post-pandemic era.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University